Results 91 to 100 of about 208,827 (271)

Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program

open access: yesJournal of Clinical Microbiology, 2019
There are sparse data to indicate the extent that macrolide-resistant Mycoplasma pneumoniae (MRMp) occurs in the United States or its clinical significance.
K. Waites   +16 more
semanticscholar   +1 more source

Antibody Serologies and Diagnostic Considerations in Reactive Infectious Mucocutaneous Eruption

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Reactive infectious mucocutaneous eruption (RIME) is an uncommon, post‐infectious mucocutaneous condition often associated with Mycoplasma pneumoniae, but which can be triggered by other pathogens. We retrospectively reviewed eight young adult patients diagnosed with RIME over a 10‐year period, all of whom had positive Mycoplasma pneumoniae ...
Aaron D. Smith   +5 more
wiley   +1 more source

Molecular Detection of Mycoplasma Pneumoniae Using P1 Gene in Patients With Chronic Obstructive Pulmonary Syndrome

open access: yesArmaghane Danesh Bimonthly Journal, 2016
Background & aim: Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by irreversible progressive obstruction of the airways which occur in three forms including; emphysema, chronic bronchitis, and small airways disease ...
S Amirian, K Amini, M Parviz
doaj  

Analysis of the correlation between PM2.5 and PM10 concentrations and the epidemiology of severe Mycoplasma pneumoniae in the PICU

open access: yesScientific Reports
This study aimed to analyze the epidemiological characteristics of severe Mycoplasma pneumoniae in the pediatric intensive care unit (PICU) of Hunan Children’s Hospital from 2020 to 2023.
Yufan Yang   +6 more
doaj   +1 more source

Case Report: Co-infection of mucormycosis with mycoplasma pneumoniae in children with diabetes mellitus: report of two rare cases

open access: yesFrontiers in Pediatrics
BackgroundMucormycosis is a rare disease characterized by its highly vascular invasiveness, rapid progression, and high mortality rate. Historically, reports on mucormycosis have been concentrated in the adult population, with few cases documented in ...
Yipaguli Simijiang   +3 more
doaj   +1 more source

Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China

open access: yesAntimicrobial Resistance and Infection Control, 2019
In China mainland, most Mycoplasma pneumoniae related studies are carried out in Beijing and Shanghai, while rare studies are performed in the other regions.
F. Zhao   +8 more
semanticscholar   +1 more source

Novel and emerging antimicrobial strategies in the management of oral infections

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley   +1 more source

Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018

open access: yesInternational Journal of Infectious Diseases, 2019
Mycoplasma pneumoniae is a threat to public health. This pathogen caused an epidemic in Hong Kong during the years 2015–2018. The reproduction number during the initial epidemic was estimated to be 1.7 for macrolide-resistant M. pneumoniae (MRMP) and 1.4
Shi Zhao   +3 more
doaj   +1 more source

Molecular Respiratory Pathogen Panels in Lung Transplantation

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Molecular respiratory pathogen panels are an innovative tool for the rapid detection of respiratory pathogens and antimicrobial resistance genes, offering the potential to improve diagnostic accuracy and guide timely antimicrobial therapy.
Andrea Lombardi
wiley   +1 more source

Home - About - Disclaimer - Privacy